BIOCQ (Biocept) Construction In Progress: $0.04 Mil (As of Jun. 2023)


BIOCQ Biocept Inc BIOCQ
16 GF Score
Price $0.00
View Full Analysis

What is Biocept Construction In Progress?

Biocept BIOCQ 16 Construction In Progress is $0.04 Mil as of Jun. 2023. GuruFocus rates BIOCQ with a GF Score™ of 16/100.

Biocept's quarterly construction in progress stayed the same from Dec. 2022 ($0.04 Mil) to Mar. 2023 ($0.04 Mil) and stayed the same from Mar. 2023 ($0.04 Mil) to Jun. 2023 ($0.04 Mil).

Biocept's annual construction in progress declined from Dec. 2020 ($0.76 Mil) to Dec. 2021 ($0.25 Mil) and declined from Dec. 2021 ($0.25 Mil) to Dec. 2022 ($0.04 Mil).

Biocept Construction In Progress Historical Data

* Premium members only.

The historical data trend for Biocept's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biocept Construction In Progress Chart

Biocept Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.12 0.63 0.76 0.25 0.04

Biocept Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.39 0.04 0.04 0.04
BIOCQ
16GF Score
Biocept Inc BIOCQ
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biocept Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of $0.04 Mil mean?
Biocept (BIOCQ) has a Construction In Progress of $0.04 Mil as of Jun. 2023. Construction in Progress records the amount of construction work that is not complete. View historical data on Biocept and its competitors.
Is Biocept's Construction In Progress too high?
Biocept's current Construction In Progress is $0.04 Mil. Overall, Biocept has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Biocept's Construction In Progress compare to IDTA and DIGP?
Biocept's Construction In Progress of $0.04 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Diagnostics & Research company?
A good Construction In Progress depends on the Medical Diagnostics & Research industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Biocept and its competitors. Biocept's current Construction In Progress is $0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biocept stock overvalued right now?
Biocept (BIOCQ) has a current Construction In Progress of $0.04 Mil. The current Construction In Progress is $0.04 Mil. Biocept's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Biocept (BIOCQ), the current Construction In Progress is $0.04 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biocept Business Description

Address 9955 Mesa Rim Road, San Diego, CA, USA, 92121
Biocept Inc develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers. In addition to its portfolio of blood-based liquid biopsy assays, Biocept has developed the CNSide cerebrospinal fluid assay that detects cancer that has metastasized to the central nervous system. Biocept's patented Target Selector technology captures and quantitatively analyzes CSF tumor cells for tumor-associated molecular markers, using technology first developed for use in blood. It is also leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic.
16GF Score

Get the complete analysis for BIOCQ

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price